Work

DNA-Encoded Chemical Library-Based Identification of Novel Inhibitors Targeting the Essential LpxH Enzyme in Gram-Negative Bacteria

Year: 2026
Type: article
Abstract: LpxH is a key enzyme in the lipid A biosynthesis pathway and a promising target for the development of new antibiotics against Gram-negative pathogens. We report the discovery and optimization of two structurally distinct LpxH inhibitor series discovered through DNA-encoded chemical library (DEL) screening. Our DEL affinity selections identified a known sulfonyl piperazine class (Series 1), and a novel biphenyl-pyrimidine scaffold (Series 2) that represented a new chemical starting point for LpxH inhibitor development. To overcome liabilities, like poor solubility and low potency, a structure-based drug design approach was used for downstream hit expansion. Optimization of Series 1 yielded compound 14, which achieved wild-type activity against E. coli. Optimization of Series 2 led to compounds 21 and 24, displaying a MIC of 16 μg/mL against efflux-defective and hyperpermeable E. coli and a MIC of 8 μg/mL against efflux-defective E. coli respectively. Target engagement was confirmed via bacterial genetic sensitization experiments, demonstrating a LpxH-mediated mechanism of action.
Language: English
Field: Chemistry
Open Access status: hybrid
Estimated APC paid: $4,500
OpenAlex ID: W7171683301
FWCI:
Cites: 39
Cited by:
Related to: 10